DYNC1LI1 and prostate carcinoma: Furthermore, dynein cytoplasmic intermediate light chain 1 (DYNC1I1) had increased expression in both LNCaP and PC-3 prostate cancer cell lines (See Supplementary Table 1 for fold change and P-values).